Efficacy of 25G+ vitrectomy for malignant glaucoma after cataract surgery / 国际眼科杂志(Guoji Yanke Zazhi)

ABSTRACT

·AIM: To observe the efficacy of 25G+ vitrectomy surgery for malignant glaucoma after cataract surgery. · METHODS: Totally 18 eyes of 18 patients with malignant glaucoma after cataract surgery were analyzed retrospectively from January 2013 to June 2016. The visual acuity was between hand moving to 0. 5 before surgery, the intraocular pressure was between 18. 3-56. 8mmHg before surgery, an average of 35. 21 ± 10. 43mmHg. The length eye axis was between 19. 60-22. 46mm, an average of 20. 63 ± 0. 48mm. The depth of anterior chamber was between 0. 98 - 1. 86mm, an average of 1. 31 ± 0. 22mm. All the patients were performed with 25G + vitrectomy. The visual acuity, anterior chamber and intraocular pressure were studied after treatment. ·RESULTS: The patients were followed up for 6-18mo with an average of 9mo. BCVA at the last follow up improved to 0. 2-0. 8, and there was significant difference compared to that before operation (P<0. 01). IOP was from 12. 3-19. 8mmHg, an average of 16. 05±2. 46mmHg, there was significant difference compared to that before operation ( t = 7. 59, P<0. 01 ). The depth of anterior chamber was between 1. 89-3. 49mm, an average of 2. 42±0. 47mm, there was significant difference compared to that before operation(t=9. 07, P<0. 01). Only one case had IOP of 8mmHg, after treatment the IOP was 15mmHg. No complications such as corneal endothelium decompensation, intraocular lens ( IOL ) capture, intraocular hemorrhage, infection and uncontrolled IOP were observed. · CONCLUSION: The 25G + vitrectomy is safe and effective for treating malignant glaucoma, controls IOP and reduces complications compared with traditional vitrectomy.